Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Mol Metab ; 79: 101840, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38036170

ABSTRACT

OBJECTIVE: Free fatty acid receptor-1 (FFAR1) is a medium- and long-chain fatty acid sensing G protein-coupled receptor that is highly expressed in the hypothalamus. Here, we investigated the central role of FFAR1 on energy balance. METHODS: Central FFAR1 agonism and virogenic knockdown were performed in mice. Energy balance studies, infrared thermographic analysis of brown adipose tissue (BAT) and molecular analysis of the hypothalamus, BAT, white adipose tissue (WAT) and liver were carried out. RESULTS: Pharmacological stimulation of FFAR1, using central administration of its agonist TUG-905 in diet-induced obese mice, decreases body weight and is associated with increased energy expenditure, BAT thermogenesis and browning of subcutaneous WAT (sWAT), as well as reduced AMP-activated protein kinase (AMPK) levels, reduced inflammation, and decreased endoplasmic reticulum (ER) stress in the hypothalamus. As FFAR1 is expressed in distinct hypothalamic neuronal subpopulations, we used an AAV vector expressing a shRNA to specifically knockdown Ffar1 in proopiomelanocortin (POMC) neurons of the arcuate nucleus of the hypothalamus (ARC) of obese mice. Our data showed that knockdown of Ffar1 in POMC neurons promoted hyperphagia and body weight gain. In parallel, these mice developed hepatic insulin resistance and steatosis. CONCLUSIONS: FFAR1 emerges as a new hypothalamic nutrient sensor regulating whole body energy balance. Moreover, pharmacological activation of FFAR1 could provide a therapeutic advance in the management of obesity and its associated metabolic disorders.


Subject(s)
Fatty Acids, Nonesterified , Pro-Opiomelanocortin , Mice , Animals , Fatty Acids, Nonesterified/metabolism , Pro-Opiomelanocortin/genetics , Pro-Opiomelanocortin/metabolism , Mice, Obese , Body Weight , Hypothalamus/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Energy Metabolism/physiology
2.
Cell Rep ; 42(8): 112949, 2023 08 29.
Article in English | MEDLINE | ID: mdl-37542717

ABSTRACT

Here, we demonstrate that hypothalamic astrocytic BMAL1 computes cyclic metabolic information to optimize energetic resources in a sexually dimorphic manner. Knockdown of BMAL1 in female astrocytes leads to negative energy balance and alters basal metabolic cycles without affecting circadian locomotor activity. Thus, astrocytic BMAL1 contributes to the control of energy balance through the modulation of the metabolic rate, hepatic and white adipose tissue lipogenesis, and the activity of brown adipose tissue. Importantly, most of these alterations are specific to hypothalamic astrocytic BMAL1. Moreover, female mice with BMAL1 knockdown in astrocytes exhibited a "male-like" metabolic obese phenotype when fed a high-fat diet. Overall, our results suggest a sexually dimorphic effect of astrocytic BMAL1 on the regulation of energy homeostasis, which may be of interest in the physiopathology of obesity and related comorbidities.


Subject(s)
ARNTL Transcription Factors , Astrocytes , Animals , Female , Male , Mice , Adipose Tissue, Brown/metabolism , ARNTL Transcription Factors/metabolism , Astrocytes/metabolism , Diet, High-Fat , Energy Metabolism , Homeostasis , Hypothalamus/metabolism , Obesity/metabolism
3.
Trends Endocrinol Metab ; 34(7): 389-391, 2023 07.
Article in English | MEDLINE | ID: mdl-37156656

ABSTRACT

Ovarian estradiol and leptin are important modulators of whole-body energy homeostasis that act in the hypothalamus. In a recent paper in Cell Metabolism, González-García et al. demonstrate that CITED1 acts as a key hypothalamic cofactor that mediates the antiobesity effects of estradiol through potentiation of the anorectic actions of leptin.


Subject(s)
Anti-Obesity Agents , Estradiol , Leptin , Humans , Arcuate Nucleus of Hypothalamus/metabolism , Estradiol/pharmacology , Hypothalamus/metabolism , Leptin/pharmacology , Anti-Obesity Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL